EGFR and non-small cell lung carcinoma: A previous study reported that a higher Brinkman index, defined as the number of cigarettes smoked per day times the smoking years, greater than 600 may be one of the predictive factors for the efficacy of nivolumab in patients with NSCLC with EGFR mutations [10].